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cryptogenic stroke was significantly higher in the PFO group (18/50,36%) vs
control group (5/34, 15%), p < 0.04.
Conclusions: 1. The prevalence of PFO decreases from the neonate to the
adult.
2. There is a high prevalence of cryptogenic stroke among adults with PFO
who have suffered a cerebrovascular event.
3. These results provide a baseline for designing future prospective stud-
ies of PFO and CV events, and randomized trials to determine the impact of
PFO closure.
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1735-41 Characteristics of Patent Foramen Ovale in Stroke
Patients: Two-dimensional and Biplane Contrast
Transesophageal Study
Stefano De Castro, Domenico Cartoni, Maurizia Rasura 1, Sergio Beni,
Alexia Anzini 1, Monica Moschini Antinori. Francesco Pelliccia, Paride Giannantoni.
Dept. of Clinical Medicine, "IE Sapienza" University, Rome, Italy; 1 Dept. of
Neuroscience, "La Sapienza'" University. Rome, Italy
Transesophageal echocardiography (TEE) has detected an increased preva-
lence of Patent Foramen Ovale (PFO) in patients with unexplained stroke. In
order to evaluate the morphological characteristics of PFO, 130 consecutive
stroke patients were studied. Of these, 21 with PFO (16%) were identified by
saline contrast TEE (Gr.A). They were matched for age and sex with 25 con-
trols (Gr.B) who had also recently had ischemic stroke but no cardiac sources
of emboli detected by TEE.
On TEE we measured: diameter of fossa ova lis (DFO); separation between
septum primum and secundum (MaxSep); thickness, length and mobility of
the fossa ovale membrane. With saline contrast injection, the number of mi-
crobubbles appearing in left atrium were counted: mild «10 mb), moderate
(10-20 mb) and severe (>20 mb).
Compared with Group B, Group A showed increased MaxSep (p < 0.0001)
and membrane mobility (p < 0.001). In addition, the degree of right to left
shunt was directly correlated to the increased in MaxSep (mild vs severe; p
< 0.0001).
In conclusion, the morphological aspect of FO in patients with ischemic
stroke and PFO, is cha racterized by an increased separation between septum
primum and septum secundum and greater mobility of the FO membrane.
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Transthoracic and Transesophageal
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To evaluate the additional value of biplane transesophageal (TEE) compared
to transthoracic (TIE) echo and the role of patent foramen ovale IPFO) and
deep vein thrombosis (DVT) in the work-up of embolic events, patients (pts)
with presumed cardiac embolic stroke or transient ischemic attack (TIA) (neu-
rovascular etiology was excluded by dopplersonography) were prospectively
studied by transthoracic and transesophageal contrast echo and phlebogra-
phy if PFO was present.
Results: 220 pts, 136 men (60 ± 15 years) were studied. In 140 of 220 pts
neuroimaging showed evidence of manifest stroke. TEE identified a poten-
tial cardiac source of embolism (left atrial thrombus [lAT], PFO, atrial septal
aneurysm [ASA], spontaneous contrast [sq, endocarditic valve lesions, mi-
tral valvular disease [MVDj and prosthetic head valves) in 43% of pts com-
pared with only 18% by TIE (p < 0.01). TEE was especially superior com-
pared to TIE for identifying LAT (10 versus 0 pts), SC (26 vs 6 pts), PFO
associated with ASA (16 vs 6 pts) and PFO alone (34 vs 20 pts). Phlebogra-
phy was performed in 50 pts with PFO. Of those pts 32 showed brain infarct
2: 1 cm diameter on neuroimaging, 18 pts had TIA. Phlebography revealed
clinically silent DVT only in pts with brain infarct (4 cases, 12.5%), no pt with
TIA had positive phlebography.
Conclusion: In this prospective study TEE detected significantly more po-
tential sources of embolism than TIE; moreover, phlebography in the pres-
ence of PFO and a clear-cut ischemic brain lesion on neuroimaging revealed
a 12.5% incidence of clinically unsuspected deep venous thrombosis. These
findings strongly suggest paradoxical embolism as an important mechanism
of stroke and support phlebography to define the relevance of PFO in the
stepwise work-up of pts with suspected cardiogenic stroke.
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Transesophageal Echocardiographic Evaluation of
Patients with Cryptogenic Stroke: Is Transthoracic
Echocardlography Helpful?
Barbara A. Pisani, Kwame O. Akosah, Christine Maxine, Walter Paulsen, Pramod
K. Mohanty. McGuire VA Medical Center and Medical College of Virginia, Richmond,
VA
Approximately 30--40% of ischemic strokes are believed to be cardiogenic
in origin. Despite its poor sensitivity transthoracic echocardiography (TIE) is
widely used to rule out cardiac source of emboli. Recently transesophagel
echocardiography (TEE) has shown higher sensitivity for detecting potential
sources of embolic stroke. However, the extent to which TEE findings alter
the initial treatment plan is unclear. We evaluated 112 patients who were
referred for TIE to rule out cardiac sources of stroke by both TIE and TEE.
Nineteen (17%) had a positive TIE compared to 64 (57%) with positive TEE.
In addition, 11 of the 64 (17%) with abnormal TEE had findings which clearly
redirected the treatment plan (myxoma = 4; thoracic aortic mass = 1; native
valve vegetation = 1; prosthetic valve vegetation = 1; valvular masses = 3).
One patient whose TIE was interpreted as left atrial ILA) myxoma had atrial
septal aneurysm (ASA) byTEE. This ASA protruded into the lA and simulated
as a "mass" on the TTE. A higher rate of detection of potential source for
emboli was noted by TEE compared to TIE for ASA (10 vs 4); left atrialllA)
and LA appendage thrombi (20 vs 3); lA myxoma (4 vs 2); vegetation (2 vs
1); patent foramen ovale (4 vs 0); spontaneous echo contrast effect (11 vs 1)
and aortic debris (10 vs 0). These observations suggest increased ability of
TEE in the detection of potential cardiac sources of emboli with significant
impact on the treatment strategy. Whether TEE should be the initial choice
of test in patients with suspected systemic emboli remains to the defined.
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There are as yet no clear guidelines regarding driving after cardioverter-
defibrillator (ICD) implantation. At this Institution, depending on their mode
of presentation patients (Pts) are advised to abstain from driving for 1-3
months after ICD implantation. Those without any syncopal episodes are
then allowed to drive if otherwise fit. To assess the safety of this approach,
we conducted a retrospective databank analysis of 635 Pts (508 males) of
mean age 62.5 ± 11.0 yrs who have been followed for a mean of 3.2 ± 2.4 yrs
(range 3 mth - 12yrs). Follow-up is complete on 629 Pts. The baseline char-
acteristics were: coronary artery disease in 80.5%, mean ejection fraction
33 ± 14% (n = 603) and 92.8% were in NYHA Class I or II. The presenting
arrhythmia was unstable VTNF in 55.5%, stablelnonsustained VT in 32.3%,
and was undocumented in 12.2%. We reviewed details on all Pts who had
had syncopal shocks (SS) or sudden cardiac death. There were 49 Pts who
had SS; lOaf these had 2:2 S5. The mean time to first SS was 18.8 ± 17.1
months after ICD implant. Only 1 Pt had a SS while driving (66 months after
first ICD implant); this did not result in a collision. There were 127 deaths
of which 22 were classified as sudden cardiac death. One Pt died suddenly
while driving 3 months post implant but did not cause injury to anyone else.
Conclusion; In this series, motor vehicle accidents resulting from syncopal
ICD shocks or sudden death occurred rarely. These results suggest that the
majority of Pts can be safely permitted to drive 1-3 months after ICD implant.
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1736-21 Should Patients be Permitted to Drive After
Cardioverter Defibfillator Implantation?
Hans-Joachim Trappe, Werner Schahl, Paul Wenzlaff. University Hospital Hannover,
Germany
It is unclear whether patients should be permitted to drive after cardioverter
defibrillator (ICD) implantation, or not. Therefore, questionnaires regarding
driVing have been completed by 162 patients (pts) who underwent ICD im-
plantation between 1/84 - 8/94. The mean follow-up of the pts population
